PRKDC and B-cell chronic lymphocytic leukemia: Overexpression of DNA-PK (both at the mRNA and protein level) has been shown to confer an inferior prognosis in CLL patients (57, 58), suggesting this kinase as a potential target for some hematological malignancies.